Intuitive Surgical (ISRG) to Release Earnings on Thursday

Intuitive Surgical (NASDAQ:ISRGGet Free Report) will be posting its quarterly earnings results after the market closes on Thursday, July 18th. Analysts expect Intuitive Surgical to post earnings of $1.53 per share for the quarter. Investors interested in registering for the company’s conference call can do so using this link.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last released its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The firm had revenue of $1.89 billion during the quarter, compared to the consensus estimate of $1.87 billion. During the same quarter in the prior year, the firm earned $1.00 EPS. The company’s revenue for the quarter was up 11.5% on a year-over-year basis. On average, analysts expect Intuitive Surgical to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $444.74 on Thursday. The business has a fifty day moving average price of $414.51 and a 200 day moving average price of $389.28. The company has a market cap of $157.75 billion, a P/E ratio of 80.28, a P/E/G ratio of 5.74 and a beta of 1.39. Intuitive Surgical has a one year low of $254.85 and a one year high of $448.10.

Analyst Ratings Changes

A number of analysts have commented on the stock. Evercore ISI increased their price objective on shares of Intuitive Surgical from $385.00 to $425.00 and gave the company an “in-line” rating in a report on Tuesday, July 2nd. Robert W. Baird lowered their price objective on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research note on Friday, April 19th. The Goldman Sachs Group began coverage on Intuitive Surgical in a report on Thursday, May 30th. They issued a “buy” rating and a $500.00 target price for the company. Citigroup lifted their price target on Intuitive Surgical from $462.00 to $512.00 and gave the stock a “buy” rating in a report on Wednesday. Finally, BTIG Research upped their price objective on shares of Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a report on Friday, April 19th. Six analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $410.32.

Get Our Latest Research Report on ISRG

Insider Activity

In related news, SVP Mark Brosius sold 175 shares of the company’s stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $389.16, for a total transaction of $68,103.00. Following the sale, the senior vice president now directly owns 883 shares of the company’s stock, valued at approximately $343,628.28. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other news, SVP Mark Brosius sold 175 shares of the company’s stock in a transaction on Monday, May 13th. The stock was sold at an average price of $389.16, for a total transaction of $68,103.00. Following the sale, the senior vice president now owns 883 shares of the company’s stock, valued at $343,628.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Alan J. Levy sold 2,000 shares of Intuitive Surgical stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $370.70, for a total value of $741,400.00. Following the completion of the transaction, the director now owns 25,319 shares of the company’s stock, valued at $9,385,753.30. The disclosure for this sale can be found here. Over the last quarter, insiders sold 17,956 shares of company stock valued at $6,927,011. 0.80% of the stock is currently owned by company insiders.

About Intuitive Surgical

(Get Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Articles

Earnings History for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.